Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes

July 2010

Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes in Canada....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Gastroenterology limit use of PPIs (omeprazole, etc)
Respiratory Allergy whether it's okay to give beta-blockers to patients with chronic obstructive pulmonary disease (COPD)
Respiratory Allergy alerts for interactions between salmeterol and strong CYP3A4 inhibitors...clarithromycin, itraconazole, ritonavir, etc
what lab tests are needed for certain drugs
Diabetes Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes
Diabetes which diabetes patients should take aspirin
Vitamins Minerals how much vitamin D is too much
Smoking Cessation more changes to Champix labelling
Gastroenterology mix-ups between Maalox products
Neurology Pain more concern about tramadol abuse and suicide
genetic tests marketed to consumers
Bites Stings What really works to repel mosquitoes, ticks, and other insects
Men s Health controversy about using testosterone in older men